Table 1.
Bladder cancer incidence and mortality in both sexes combined in 2020 by world region and human development index level
| Region | Population | Incidence |
Mortality |
||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
No. (%), in thousands
|
Number of cases
|
Percentage of world total
|
ASIR (95% CI)
|
Cumulative risk*
|
Number of deaths
|
Percentage of world total
|
ASMR (95% CI)
|
Cumulative risk*
|
|
Europe
|
|
|
|
|
|
|
|
|
|
| Northern Europe |
106 261 (1.4) |
23 333 |
4.1 |
8.7 (8.6-8.9) |
2.87 |
9563 |
4.5 |
2.7 (2.7-2.8) |
1.39 |
| Western Europe |
196 146 (2.5) |
68 143 |
11.9 |
13.0 (13.0-13.2) |
3.92 |
20 866 |
9.8 |
3.0 (3.0-3.0) |
1.40 |
| Southern Europe |
153 423 (2.0) |
61 480 |
10.7 |
15.3 (15.3-15.6) |
4.29 |
17 931 |
8.4 |
3.3 (3.2-3.4) |
1.48 |
| Central and Eastern Europe |
293 013 (3.8) |
51 027 |
8.9 |
8.6 (8.5-8.7) |
2.20 |
18 929 |
8.9 |
2.8 (2.7-2.8) |
1.00 |
|
America
|
|
|
|
|
|
|
|
|
|
| Northern America |
368 870 (4.7) |
89 997 |
15.7 |
10.9 (10.8-10.9) |
3.59 |
21 045 |
9.9 |
2.1 (2.1-2.2) |
1.04 |
| South America |
430 760 (5.5) |
27 159 |
4.7 |
4.8 (4.8-4.9) |
1.58 |
10 108 |
4.8 |
1.6 (1.6-1.7) |
0.73 |
| Central America |
179 670 (2.3) |
4119 |
0.7 |
2.2 (2.1-2.3) |
0.68 |
1690 |
0.8 |
0.8 (0.8-0.9) |
0.36 |
| Caribbean |
43 532 (0.6) |
2562 |
0.4 |
4.1 (3.9-4.2) |
1.36 |
1302 |
0.6 |
1.8 (1.8-2.0) |
0.82 |
|
Asia
|
|
|
|
|
|
|
|
|
|
| Eastern Asia |
1 678 090 (21.5) |
132 316 |
23.1 |
4.3 (4.3-4.4) |
1.46 |
54 206 |
25.5 |
1.6 (1.6-1.6) |
0.81 |
| South-Central Asia |
2 014 709 (25.8) |
35 949 |
6.3 |
1.9 (1.9-2.0) |
0.51 |
18 243 |
8.6 |
1.0 (1.0-1.0) |
0.34 |
| South-Eastern Asia |
668 620 (8.6) |
18 911 |
3.3 |
2.6 (2.5-2.60) |
0.85 |
10 327 |
4.9 |
1.4 (1.3-1.4) |
0.65 |
| Western Asia |
278 429 (3.6) |
20 915 |
3.6 |
8.9 (8.8-9.1) |
2.38 |
7834 |
3.7 |
3.2 (3.1-3.2) |
1.31 |
|
Oceania
|
|
|
|
|
|
|
|
|
|
| Australia and New Zealand |
30 322 (0.4) |
3923 |
0.7 |
5.5 (5.3-5.6) |
2.12 |
1615 |
0.8 |
1.8 (1.7-1.9) |
1.05 |
| Melanesia |
11 123 (0.1) |
201 |
<0.1 |
2.8 (2.4-3.3) |
0.79 |
104 |
<0.1 |
1.6 (1.3-1.9) |
0.56 |
| Micronesia/Polynesia |
1233 (<0.1) |
47 |
<0.1 |
3.8 (2.4-5.1) |
0.47 |
26 |
<0.1 |
2.1 (1.1-3.2) |
0.28 |
|
Africa
|
|
|
|
|
|
|
|
|
|
| Northern Africa |
246 233 (3.2) |
18 589 |
3.2 |
8.9 (8.8-9.0) |
2.52 |
10 787 |
5.1 |
5.2 (5.1-5.3) |
2.17 |
| Western Africa |
401 861 (5.2) |
4139 |
0.7 |
2.0 (1.9-2.0) |
0.49 |
2397 |
1.1 |
1.3 (1.2-1.3) |
0.37 |
| Southern Africa |
67 504 (0.9) |
2208 |
0.4 |
4.1 (3.9-4.3) |
1.28 |
853 |
0.4 |
1.6 (1.5-1.7) |
0.59 |
| Middle Africa |
179 595 (2.3) |
1366 |
0.2 |
1.6 (1.5-1.7) |
0.47 |
784 |
0.4 |
1.0 (0.9-1.0) |
0.35 |
| Eastern Africa |
445 406 (5.7) |
6894 |
1.2 |
3.2 (3.1-3.2) |
0.94 |
3926 |
1.8 |
1.9 (1.8-1.9) |
0.71 |
|
HDI
|
|
|
|
|
|
|
|
|
|
| Very high HDI |
1 564 286 (20.1) |
356 601 |
62.2 |
10.2 (10.2-10.2) |
3.13 |
108 713 |
51.2 |
2.5 (2.5-2.5) |
1.15 |
| High HDI |
2 909 468 (37.3) |
164 626 |
28.7 |
4.1 (4.1-4.1) |
1.26 |
75 297 |
35.4 |
1.8 (1.8-1.8) |
0.81 |
| Medium HDI |
2 327 556 (29.9) |
38 712 |
6.8 |
1.9 (1.9-1.9) |
0.49 |
20 719 |
9.8 |
1.0 (1.0-1.0) |
0.33 |
| Low HDI |
990 175(12.7) |
13 025 |
2.3 |
2.6 (2.5-2.6) |
0.76 |
7693 |
3.6 |
1.7 (1.7-1.8) |
0.61 |
|
WHO Region
|
|
|
|
|
|
|
|
|
|
| WHO Africa |
1 124 061 (14.4) |
17 526 |
3.1 |
3.1 (3.0-3.1) |
0.93 |
9655 |
4.5 |
1.8 (1.8-1.8) |
0.69 |
| WHO Americas |
1 024 551 (13.1) |
123 837 |
21.6 |
7.3 (7.3-7.4) |
2.52 |
34 145 |
16.1 |
1.8 (1.8-1.9) |
0.86 |
| WHO East Mediterranean |
764 753 (9.8) |
31 204 |
5.4 |
5.9 (5.9-6.0) |
1.65 |
16 468 |
7.8 |
3.2 (3.2-3.3) |
1.31 |
| WHO Europe |
929 738 (11.9) |
221 298 |
38.6 |
11.0 (11.0-11.1) |
3.22 |
73 363 |
34.5 |
3.0 (3.0-3.0) |
1.30 |
| WHO South-East Asia |
2 040 083 (26.1) |
39 118 |
6.8 |
2.0 (2.0-2.0) |
0.57 |
20 890 |
9.8 |
1.0 (1.0-1.0) |
0.40 |
| WHO Western Pacific |
1 928 975 (24.7) |
140 171 |
24.5 |
4.2 (4.2-4.3) |
1.41 |
57 965 |
27.3 |
1.6 (1.6-1.6) |
0.79 |
| World | 7 794 799 (100) | 573 278 | 100.0 | 5.6 (5.6-5.6) | 1.88 | 212 536 | 100.0 | 1.9 (1.9-1.9) | 0.89 |
ASIR – age-standardised incidence rate per 100 000 person-years, CI – confidence interval, ASMR – age-standardised mortality rate per 100 000 person-years, HDI – Human Development Index, WHO – World Health Organization
*Cumulative risk of being diagnosed with or dying from bladder cancer until 74 years of age in 2020.